These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22714558)

  • 1. Selective glucocorticoid receptor modulation maintains bone mineral density in mice.
    Thiele S; Ziegler N; Tsourdi E; De Bosscher K; Tuckermann JP; Hofbauer LC; Rauner M
    J Bone Miner Res; 2012 Nov; 27(11):2242-50. PubMed ID: 22714558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the selective glucocorticoid receptor modulator compound A on bone metabolism and inflammation in male mice with collagen-induced arthritis.
    Rauner M; Thiele S; Sinningen K; Winzer M; Salbach-Hirsch J; Gloe I; Peschke K; Haegeman G; Tuckermann JP; Hofbauer LC
    Endocrinology; 2013 Oct; 154(10):3719-28. PubMed ID: 23885015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociation of osteogenic and immunological effects by the selective glucocorticoid receptor agonist, compound A, in human bone marrow stromal cells.
    Rauner M; Goettsch C; Stein N; Thiele S; Bornhaeuser M; De Bosscher K; Haegeman G; Tuckermann J; Hofbauer LC
    Endocrinology; 2011 Jan; 152(1):103-12. PubMed ID: 21084452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation.
    Rauch A; Gossye V; Bracke D; Gevaert E; Jacques P; Van Beneden K; Vandooren B; Rauner M; Hofbauer LC; Haegeman G; Elewaut D; Tuckermann JP; De Bosscher K
    FASEB J; 2011 Apr; 25(4):1323-32. PubMed ID: 21233489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MLO-Y4 osteocyte-like cells support osteoclast formation and activation.
    Zhao S; Zhang YK; Harris S; Ahuja SS; Bonewald LF
    J Bone Miner Res; 2002 Nov; 17(11):2068-79. PubMed ID: 12412815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells.
    Humphrey EL; Williams JH; Davie MW; Marshall MJ
    Bone; 2006 May; 38(5):652-61. PubMed ID: 16298558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
    Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
    J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoprotegerin prevents glucocorticoid-induced osteocyte apoptosis in mice.
    Weinstein RS; O'Brien CA; Almeida M; Zhao H; Roberson PK; Jilka RL; Manolagas SC
    Endocrinology; 2011 Sep; 152(9):3323-31. PubMed ID: 21771887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
    Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
    Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms.
    O'Sullivan S; Naot D; Callon K; Porteous F; Horne A; Wattie D; Watson M; Cornish J; Browett P; Grey A
    J Bone Miner Res; 2007 Nov; 22(11):1679-89. PubMed ID: 17663639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid receptor signaling in bone cells.
    Moutsatsou P; Kassi E; Papavassiliou AG
    Trends Mol Med; 2012 Jun; 18(6):348-59. PubMed ID: 22578718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteogenic growth peptide effects on primary human osteoblast cultures: potential relevance for the treatment of glucocorticoid-induced osteoporosis.
    Spreafico A; Frediani B; Capperucci C; Leonini A; Gambera D; Ferrata P; Rosini S; Di Stefano A; Galeazzi M; Marcolongo R
    J Cell Biochem; 2006 Jul; 98(4):1007-20. PubMed ID: 16795077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditioned medium from osteocytes stimulates the proliferation of bone marrow mesenchymal stem cells and their differentiation into osteoblasts.
    Heino TJ; Hentunen TA; Väänänen HK
    Exp Cell Res; 2004 Apr; 294(2):458-68. PubMed ID: 15023534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HLA-B27 transgenic rat, a model of spondyloarthritis, has decreased bone mineral density and increased RANKL to osteoprotegerin mRNA ratio.
    Rauner M; Stupphann D; Haas M; Fert I; Glatigny S; Sipos W; Breban M; Pietschmann P
    J Rheumatol; 2009 Jan; 36(1):120-6. PubMed ID: 19040304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor.
    Rauch A; Seitz S; Baschant U; Schilling AF; Illing A; Stride B; Kirilov M; Mandic V; Takacz A; Schmidt-Ullrich R; Ostermay S; Schinke T; Spanbroek R; Zaiss MM; Angel PE; Lerner UH; David JP; Reichardt HM; Amling M; Schütz G; Tuckermann JP
    Cell Metab; 2010 Jun; 11(6):517-31. PubMed ID: 20519123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio.
    Seriwatanachai D; Thongchote K; Charoenphandhu N; Pandaranandaka J; Tudpor K; Teerapornpuntakit J; Suthiphongchai T; Krishnamra N
    Bone; 2008 Mar; 42(3):535-46. PubMed ID: 18166509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid receptor 1 mediates glucocorticoid-induced bone loss in rats by perturbing bone mineral acquisition and marrow adipogenesis.
    Ko JY; Wu RW; Kuo SJ; Chen MW; Yeh DW; Ke HC; Wu SL; Wang FS
    Arthritis Rheum; 2012 Apr; 64(4):1204-14. PubMed ID: 22127784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1 plays an important role in the bone metabolism under physiological conditions.
    Lee YM; Fujikado N; Manaka H; Yasuda H; Iwakura Y
    Int Immunol; 2010 Oct; 22(10):805-16. PubMed ID: 20679512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of glucocorticoids on serum markers of osteoclasts, osteoblasts, and osteocytes.
    Brabnikova Maresova K; Pavelka K; Stepan JJ
    Calcif Tissue Int; 2013 Apr; 92(4):354-61. PubMed ID: 23247536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
    Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
    J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.